Myriad Genetics (MYGN) stock is downgraded from a "Buy" to "Hold" due to flat Q3 2025 earnings and limited near-term revenue ...
Q3 2025 Earnings Call Transcript November 4, 2025 SOPHiA GENETICS S.A. misses on earnings expectations. Reported EPS is $-0.3 ...
A new 3D human brain tissue platform developed by MIT researchers is the first to integrate all major brain cell types, ...
Wetlands are an important part of the ecological system, providing a myriad of benefits for people, wildlife and the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback